News and Press Releases

Press releases

in the news

June 17, 2026

Theralase® Technologies ($TLT.V | $TLTFF): A Novel Drug-and-Laser Approach to Bladder Cancer

Watch the video

June 17, 2026

Theralase® AGSM Meeting Recording - June 17th 2026

Watch the video

June 9, 2026

Theralase® 1st Quarter 2026 Financial Results & Clinical Study Update

Watch the video

May 12, 2026

Theralase® Fiscal Year 2025 Financial Results & Clinical Study Update

Watch the video

NOVEMBER 19, 2025

Theralase®'s 3Q2025 Quarterly Call

Watch the video
August 31, 2015
The View From The C-Suite – Roger Dumoulin-White, P. Eng, President & CEO, Theralase Technologies Inc.
Watch the video

June 11, 2025

AGSM Question & Answer Session With CEO

Watch the video

June 9, 2025

Theralase® Investor Conference Call

Watch the video

July 6, 2023

Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer

Watch the video

may 18, 2023

Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni

Watch the video
B-TV Theralase® an innovative medical technology for bladder cancer treatment
August 16, 2018

BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018

Watch the video
October 10, 2017
Invest in Ontario – Toronto-based Firm Advances Light-activated Cancer Treatment Through SOSCIP Collaboration Program
Watch the video
December 20, 2016
Stock News Now – Update with Theralase Technologies (TSX-V: TLT) (OTC PINK: TLTFF) December 2016
Watch the video
BTv – Theralase Technologies is Destroying Cancer Cells
November 12, 2016

BTv – Theralase Technologies is Destroying Cancer Cells – 2016

Watch the video
BTv – Using Lasers to Heal Pain and Treat Cancer
February 12, 2016

BTv – Using Lasers to Heal Pain and Treat Cancer – 2016

Watch the video
Theralase® Communication

Let's Stay in Touch

Sign up to receive periodic updates from Theralase Technologies Inc.